CANCER OF PROSTATE
Clinical trials for CANCER OF PROSTATE explained in plain language.
Never miss a new study
Get alerted when new CANCER OF PROSTATE trials appear
Sign up with your email to follow new studies for CANCER OF PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug tested to shrink prostate tumors before surgery
Disease control Recruiting nowThis is a small, early-stage study to see if a drug called dapagliflozin, normally used for diabetes, is safe and tolerable for men with aggressive prostate cancer before they have surgery to remove the prostate. Researchers want to see if taking the pill daily for four weeks bef…
Matched conditions: CANCER OF PROSTATE
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Two treatments vs. five: new hope for prostate cancer Patients' quality of life
Disease control Recruiting nowThis study is testing whether a shorter, two-session radiation treatment is as effective as the standard five-session treatment for men with low-risk prostate cancer. The main goal is to see if the shorter treatment can better preserve patients' sexual quality of life and cause f…
Matched conditions: CANCER OF PROSTATE
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for slowing advanced prostate cancer
Disease control Recruiting nowThis study is testing whether adding an experimental immunotherapy drug called PDS01ADC to standard chemotherapy (docetaxel) is safe and can help men whose prostate cancer has spread. It is for men with two types of advanced prostate cancer: one that still responds to hormone the…
Matched conditions: CANCER OF PROSTATE
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug trial aims to supercharge immune system against prostate cancer
Disease control Recruiting nowThis study is testing whether adding a new immune-boosting drug called M9241 to standard radiation and hormone therapy can help the body's own defenses fight prostate cancer better. It will involve about 65 men with high- or intermediate-risk prostate cancer that hasn't spread. T…
Matched conditions: CANCER OF PROSTATE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC
-
Magic mushroom therapy tested for cancer Patients' anxiety
Symptom relief Recruiting nowThis study is testing whether a therapy session using the psychedelic compound psilocybin (from 'magic mushrooms') can help reduce anxiety in people struggling to adjust to a cancer diagnosis. About 87 adults will receive one of three different doses of psilocybin during a guided…
Matched conditions: CANCER OF PROSTATE
Phase: PHASE2 • Sponsor: Psyence Australia Pty Ltd • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Massive 10,000-Man study aims to decode prostate cancer scans
Knowledge-focused Recruiting nowThis study aims to collect detailed medical and imaging data from 10,000 men with or at risk for prostate cancer. Researchers will analyze this information over at least five years to understand how different scan results relate to a patient's disease and outcomes. The goal is to…
Matched conditions: CANCER OF PROSTATE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Scientists seek blood clues to prostate Cancer's deadly turn
Knowledge-focused Recruiting nowThis study aims to understand why some prostate cancers stop responding to standard treatments by collecting blood samples from patients. Researchers will analyze the genetic material in the blood to look for differences that might explain why the disease becomes more aggressive …
Matched conditions: CANCER OF PROSTATE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC
-
Scientists test if exercise or dieting better slows prostate cancer growth
Knowledge-focused Recruiting nowThis study aims to understand whether a week of daily exercise or a week of calorie restriction is better at slowing prostate tumor growth while preserving muscle in men with prostate cancer. Researchers will measure protein changes in tumor and muscle tissue after the 7-day inte…
Matched conditions: CANCER OF PROSTATE
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:20 UTC